303 related articles for article (PubMed ID: 19844076)
1. Sequence variants in BMPR2 and genes involved in the serotonin and nitric oxide pathways in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: relation to clinical parameters and comparison with left heart disease.
Ulrich S; Szamalek-Hoegel J; Hersberger M; Fischler M; Garcia JS; Huber LC; Grünig E; Janssen B; Speich R
Respiration; 2010; 79(4):279-87. PubMed ID: 19844076
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of the serotonin transporter, but not the 2a receptor or nitric oxide synthetase, are associated with pulmonary hypertension in chronic obstructive pulmonary disease.
Ulrich S; Hersberger M; Fischler M; Nussbaumer-Ochsner Y; Treder U; Russi EW; Speich R
Respiration; 2010; 79(4):288-95. PubMed ID: 19556740
[TBL] [Abstract][Full Text] [Related]
3. Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension.
Willers ED; Newman JH; Loyd JE; Robbins IM; Wheeler LA; Prince MA; Stanton KC; Cogan JA; Runo JR; Byrne D; Humbert M; Simonneau G; Sztrymf B; Morse JA; Knowles JA; Roberts KE; McElroy JJ; Barst RJ; Phillips JA
Am J Respir Crit Care Med; 2006 Apr; 173(7):798-802. PubMed ID: 16339917
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension.
Rosenzweig EB; Morse JH; Knowles JA; Chada KK; Khan AM; Roberts KE; McElroy JJ; Juskiw NK; Mallory NC; Rich S; Diamond B; Barst RJ
J Heart Lung Transplant; 2008 Jun; 27(6):668-74. PubMed ID: 18503968
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of childhood pulmonary arterial hypertension in BMPR2 and ALK1 mutation carriers.
Chida A; Shintani M; Yagi H; Fujiwara M; Kojima Y; Sato H; Imamura S; Yokozawa M; Onodera N; Horigome H; Kobayashi T; Hatai Y; Nakayama T; Fukushima H; Nishiyama M; Doi S; Ono Y; Yasukouchi S; Ichida F; Fujimoto K; Ohtsuki S; Teshima H; Kawano T; Nomura Y; Gu H; Ishiwata T; Furutani Y; Inai K; Saji T; Matsuoka R; Nonoyama S; Nakanishi T
Am J Cardiol; 2012 Aug; 110(4):586-93. PubMed ID: 22632830
[TBL] [Abstract][Full Text] [Related]
6. [Bone morphogenetic protein type II receptor gene promoter mutation-142G > A in a patient with familial pulmonary arterial hypertension].
Li W; Hu H
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):230-4. PubMed ID: 19552837
[TBL] [Abstract][Full Text] [Related]
7. Association between serotonin transporter (SERT) gene polymorphism and idiopathic pulmonary arterial hypertension: a meta-analysis and review of the literature.
Zhang H; Xu M; Xia J; Qin RY
Metabolism; 2013 Dec; 62(12):1867-75. PubMed ID: 24075737
[TBL] [Abstract][Full Text] [Related]
8. 5'UTR repeat polymorphisms of the BMPR2 gene in children with pulmonary hypertension associated with congenital heart disease.
Limsuwan A; Choubtum L; Wattanasirichaigoon D
Heart Lung Circ; 2013 Mar; 22(3):204-10. PubMed ID: 23098893
[TBL] [Abstract][Full Text] [Related]
9. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
[TBL] [Abstract][Full Text] [Related]
10. BMPR2 mutations influence phenotype more obviously in male patients with pulmonary arterial hypertension.
Liu D; Wu WH; Mao YM; Yuan P; Zhang R; Ju FL; Jing ZC
Circ Cardiovasc Genet; 2012 Oct; 5(5):511-8. PubMed ID: 22923421
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations.
Pfarr N; Szamalek-Hoegel J; Fischer C; Hinderhofer K; Nagel C; Ehlken N; Tiede H; Olschewski H; Reichenberger F; Ghofrani AH; Seeger W; Grünig E
Respir Res; 2011 Jul; 12(1):99. PubMed ID: 21801371
[TBL] [Abstract][Full Text] [Related]
12. 5-HTT, BMPR2, EDN1, ENG, KCNA5 gene polymorphisms and susceptibility to pulmonary arterial hypertension: A meta-analysis.
Jiao YR; Wang W; Lei PC; Jia HP; Dong J; Gou YQ; Chen CL; Cao J; Wang YF; Zhu YK
Gene; 2019 Jan; 680():34-42. PubMed ID: 30218748
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.
Sztrymf B; Coulet F; Girerd B; Yaici A; Jais X; Sitbon O; Montani D; Souza R; Simonneau G; Soubrier F; Humbert M
Am J Respir Crit Care Med; 2008 Jun; 177(12):1377-83. PubMed ID: 18356561
[TBL] [Abstract][Full Text] [Related]
14. [Study of the BMPR2 gene in patients with pulmonary arterial hypertension].
Portillo K; Santos S; Madrigal I; Blanco I; Paré C; Borderías L; Peinado VI; Roca J; Milà M; Barberà JA
Arch Bronconeumol; 2010 Mar; 46(3):129-34. PubMed ID: 20096498
[TBL] [Abstract][Full Text] [Related]
15. A novel mutation in the BMPR2 gene in familial pulmonary arterial hypertension.
Fu LJ; Zhou AQ; Huang MR; Shen SH; Shen J; Zhang ZF; Li F
Chin Med J (Engl); 2008 Mar; 121(5):399-404. PubMed ID: 18364108
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
[TBL] [Abstract][Full Text] [Related]
17. Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension.
Li M; Vattulainen S; Aho J; Orcholski M; Rojas V; Yuan K; Helenius M; Taimen P; Myllykangas S; De Jesus Perez V; Koskenvuo JW; Alastalo TP
Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1118-28. PubMed ID: 24433082
[TBL] [Abstract][Full Text] [Related]
18. Demographic features, BMPR2 status and outcomes in distal chronic thromboembolic pulmonary hypertension.
Suntharalingam J; Machado RD; Sharples LD; Toshner MR; Sheares KK; Hughes RJ; Jenkins DP; Trembath RC; Morrell NW; Pepke-Zaba J
Thorax; 2007 Jul; 62(7):617-22. PubMed ID: 17287300
[TBL] [Abstract][Full Text] [Related]
19. Oestrogen receptor alpha in pulmonary hypertension.
Wright AF; Ewart MA; Mair K; Nilsen M; Dempsie Y; Loughlin L; Maclean MR
Cardiovasc Res; 2015 May; 106(2):206-16. PubMed ID: 25765937
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of genetic mutation and modifier genes in pulmonary arterial hypertension].
Fujiwara M; Yagi H; Matsuoka R; Saji T
Nihon Rinsho; 2008 Nov; 66(11):2071-5. PubMed ID: 19051722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]